Nanovalent Pharmaceuticals
Pre-clinicalSignificantly improving upon the delivery, safety and performance of both existing and developing cancer therapeutics.
Founded
2021
Focus
AntibodiesBiologicsNanotechnology
About
Significantly improving upon the delivery, safety and performance of both existing and developing cancer therapeutics.
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile